Mucormycosis infection in severe COVID-19 patient with multiple underlying health conditions

Zahra Heydarifard1, Moslem Safaei2, Sevrin Zadheidar1

  • 1Virology Department School of Public Health Tehran University of Medical Sciences Tehran Iran.

Clinical Case Reports
|November 8, 2021
PubMed

Insights

Patients with underlying health conditions face increased risk of invasive fungal infections after COVID-19. Uncontrolled diabetes mellitus heightens susceptibility to severe COVID-19 and mucormycosis.

Area of Science:

  • Infectious Diseases
  • Endocrinology
  • Critical Care Medicine

Background:

  • COVID-19 poses significant risks, particularly for individuals with pre-existing health issues.
  • Invasive fungal infections (IFIs) are a known complication in immunocompromised patients.
  • Mucormycosis is a severe, life-threatening fungal infection.

Observation:

  • Patients recovering from COVID-19 exhibit increased vulnerability to IFIs.
  • A notable correlation exists between uncontrolled diabetes mellitus and severe COVID-19 outcomes.
  • Uncontrolled diabetes mellitus appears to be a significant risk factor for developing mucormycosis post-COVID-19.

Findings:

  • Uncontrolled diabetes mellitus is linked to heightened susceptibility to severe COVID-19.
  • Patients with uncontrolled diabetes mellitus are at increased risk for invasive fungal infections, including mucormycosis, following COVID-19.
  • This suggests a complex interplay between metabolic dysregulation, viral infection, and opportunistic fungal pathogens.

Implications:

  • Highlights the critical need for vigilant monitoring of diabetic patients post-COVID-19 for IFIs.
  • Suggests enhanced glycemic control strategies may mitigate risks of severe COVID-19 and secondary fungal infections.
  • Emphasizes the importance of multidisciplinary care involving infectious disease specialists and endocrinologists for at-risk populations.

Related Concept Videos

Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
273
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
406
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.4K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.3K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
247
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
391